FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to therapy, and deals with application of angiogenin or its agonists for treating diseases mediated by impairment of myostatin activity. For this purpose an efficient amount of angiogenin or its agonist is introduced.
EFFECT: invention ensures growth and normalisation of muscular tissue function due to stimulation of differentiation of muscular cells in muscular tubes.
10 cl, 15 dwg, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| B-CELLS, GENETICALLY MODIFIED FOR SECRETION OF FOLLISTATIN, AND METHODS OF USING THEM FOR TREATING FOLLISTATIN-RELATED DISEASES, CONDITIONS, DISORDERS AND FOR INCREASING MUSCLE GROWTH AND STRENGTH | 2019 |
|
RU2832170C2 |
| MILK FRACTIONS ENRICHED WITH ANGIOGENINE | 2009 |
|
RU2538654C2 |
| NUETRALISING ANTIBODIES AGAINST GDF-8 AND THEIR APPLICATION | 2003 |
|
RU2360925C2 |
| USE OF TRYPTOPHAN METABOLITES FOR THE TREATMENT OF MUSCULAR ATROPHY | 2017 |
|
RU2806346C2 |
| RECOMBINANT ANGIOGENIN IN COSMETIC AND PHARMACEUTICAL COMPOSITIONS | 2021 |
|
RU2784355C1 |
| RECOMBINANT ANGIOGENIN IN COSMETIC AND PHARMACEUTICAL COMPOSITIONS | 2022 |
|
RU2805144C1 |
| STABILISED INSULIN-LIKE GROWTH FACTOR POLYPEPTIDES | 2007 |
|
RU2477287C2 |
| ANTIBODY AGAINST IGF-I RECEPTOR | 2018 |
|
RU2785305C2 |
| APPLICATION OF GROWTH HORMONE FRAGMENTS | 2012 |
|
RU2639474C2 |
| APPLYING MYOSTATIC INHIBITORS (GDF8) IN COMBINATION WITH CORTICOSTEROIDS FOR TREATING NERVOUS-MUSCULAR DISEASES | 2004 |
|
RU2322261C2 |
